Skip to content

Effect of tranexamic acid on postpartum hemorrhage.

A comparison between the effect of tranexamic acid and placebo on the amount of hemorrhage in women following vaginal delivery and its adverse effects.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20091023002624N22
Enrollment
200
Registered
2017-12-20
Start date
2016-03-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: hemorrhage following delivery. Condition 2: hemorrhage following delivery. Condition 3: hemorrhage following delivery. Condition 4: complications after delivery. Condition 5: hemorrhage following delivery. haemorrhage after delivery of fetus or infant Third-stage haemorrhage Complication of labour and delivery, unspecified Other specified complications of labour and delivery Other immediate postpartum haemorrhage

Interventions

Intervention 1: Intervention group received 10 mg/kg intravenous TXA in 100 mL normal saline. Intervention 2: Control group received one vial of distilled water (as placebo) in 100 mL normal saline.
Treatment - Drugs
Prevention
Intervention group received 10 mg/kg intravenous TXA in 100 mL normal saline.
Control group received one vial of distilled water (as placebo) in 100 mL normal saline.

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Pregnant singleton gestational age between 37-42 weeks normal blood pressure (< 140/90 mmHg) informed consent for the study

Exclusion criteria

Exclusion criteria: history of coagulopathy pre-eclampsia placental abruption hypersensitivity to tranexamic acid Body Mass Index(BMI) of more than 30 episiotomy history of cardiac, hepatic, renal and neurologic disorders

Design outcomes

Primary

MeasureTime frame
Hemoglobin level. Timepoint: At the time of admission and 6 hours after delivery . Method of measurement: blood test.

Secondary

MeasureTime frame
Urine output. Timepoint: was checked at the beginning of labor and then during 6 hours after delivery ; every 15 minutes after labor for the first hour and then every 30 minutes for the second hour and finally every hour for another 4 hours. Method of measurement: Data sheets, Monitoring of urine output.;Respiratory rate. Timepoint: was checked at the beginning of labor and then during 6 hours after delivery ; every 15 minutes after labor for the first hour and then every 30 minutes for the second hour and finally every hour for another 4 hours. Method of measurement: Data sheets, Monitoring of respiratory rate.;Blood pressure. Timepoint: was checked at the beginning of labor and then during 6 hours after delivery ; every 15 minutes after labor for the first hour and then every 30 minutes for the second hour and finally every hour for another 4 hours. Method of measurement: Data sheets, Monitoring of blood pressure.;Pulse rate. Timepoint: was checked at the beginning of labor and then during 6 hours after delivery ; every 15 minutes after labor for the first hour and then every 30 minutes for the second hour and finally every hour for another 4 hours. Method of measurement: Data sheets,Monitoring of pulse rate.;Need of additional uterotonic agents . Timepoint: Any time after delivery. Method of measurement: Data sheets, using uterotonic agents.;Need of blood transfusion. Timepoint: Any time after delivery up to 24 hours. Method of measurement: blood transfusion.;Need to surgical interventions. Timepoint: Any time after delivery up to 24 hours. Method of measurement: surgical interventions.;Side effects of Tranexamic acid. Timepoint: Any time after delivery up to 42 days. Method of measurement: Data sheets.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Kashanian

Iran University of Medical Sciences

maryamkashanian@yahoo.com+98 21 5563 3244

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 15, 2026